Price & volume screen · refreshed after the Nov 11, 2026 close
Six-month momentum leaders: Healthcare
Large companies with the strongest six-month price performance. Ranks companies worth at least $1B by their six-month split-adjusted return.
| # | Company | Price | 1M | 6M | From high | Mkt cap |
|---|---|---|---|---|---|---|
| 101 | PVLAPalvella TherapeuticsHealthcare | $165.96 | +29.1% | +37.6% | −5.7% | $2.43B |
| 102 | DXCMDexComHealthcare | $80.33 | −5.6% | +37.2% | −13.0% | $29.96B |
| 103 | WSTWest Pharmaceutical ServicesHealthcare | $414.44 | +11.5% | +37.1% | −0.5% | $28.87B |
| 104 | EXELExelixisHealthcare | $70.26 | +18.1% | +37.0% | −3.4% | $17.14B |
| 105 | DGXQuest DiagnosticsHealthcare | $257.74 | +11.8% | +35.0% | −0.7% | $28.45B |
| 106 | NEOGNeogenHealthcare | $11.68 | −0.5% | +34.3% | −16.5% | $2.55B |
| 107 | AXGNAxogenHealthcare | $53.96 | +49.2% | +33.9% | 0.0% | $3.22B |
| 108 | GEHCGE HealthCare TechnologiesHealthcare | $82.77 | +20.3% | +33.7% | −6.1% | $37.42B |
| 109 | TNDMTandem Diabetes CareHealthcare | $18.84 | +13.2% | +33.5% | −33.3% | $1.31B |
| 110 | TDOCTeladoc HealthHealthcare | $9.06 | +50.9% | +33.4% | −6.8% | $1.65B |
| 111 | MDTMedtronicHealthcare | $101.12 | +8.7% | +32.7% | −4.0% | $129.35B |
| 112 | IDXXIdexx LaboratoriesHealthcare | $698.26 | +34.2% | +32.1% | −8.9% | $55.01B |
| 113 | ADUSAddus HomeCareHealthcare | $124.63 | +8.8% | +31.9% | −2.6% | $2.32B |
| 114 | EHCEncompass HealthHealthcare | $141.61 | +13.9% | +31.7% | −0.6% | $13.90B |
| 115 | BLCOBausch + LombHealthcare | $21.33 | +34.9% | +31.3% | −0.2% | $7.63B |
| 116 | ABTAbbott LaboratoriesHealthcare | $109.98 | +7.2% | +31.2% | −15.8% | $190.48B |
| 117 | RPRXRoyalty PharmaHealthcare | $69.74 | +23.3% | +31.0% | 0.0% | $31.05B |
| 118 | REGNRegeneron PharmaceuticalsHealthcare | $941.69 | +25.0% | +30.8% | −3.3% | $97.42B |
| 119 | CORTCorcept TherapeuticsHealthcare | $74.63 | −36.7% | +30.7% | −39.6% | $8.07B |
| 120 | ARQTArcutis BiotherapeuticsHealthcare | $28.24 | +8.2% | +30.2% | −17.1% | $3.57B |
| 121 | ANROAlto NeuroscienceHealthcare | $29.73 | +34.6% | +30.1% | −18.9% | $1.17B |
| 122 | BTSGBrightSpring Health ServicesHealthcare | $73.18 | +16.8% | +29.5% | 0.0% | $14.56B |
| 123 | MMM3MHealthcare | $190.29 | +16.9% | +29.4% | −1.9% | $98.14B |
| 124 | PTGXProtagonist TherapeuticsHealthcare | $134.32 | −3.0% | +29.3% | −15.3% | $8.77B |
| 125 | MRKMerck & Co.Healthcare | $146.55 | +3.2% | +29.2% | −6.3% | $361.28B |
| 126 | SLSSELLAS Life Sciences GroupHealthcare | $8.44 | −32.0% | +29.2% | −45.4% | $1.70B |
| 127 | ZBHZimmer Biomet HoldingsHealthcare | $106.69 | +15.9% | +29.0% | −3.1% | $20.19B |
| 128 | EWEdwards LifesciencesHealthcare | $104.88 | +23.0% | +28.9% | 0.0% | $60.31B |
| 129 | CHEChemedHealthcare | $545.34 | +8.9% | +28.6% | −1.3% | $7.07B |
| 130 | MDPediatrix Medical GroupHealthcare | $30.74 | +15.5% | +28.2% | −6.3% | $2.40B |
| 131 | GILDGilead SciencesHealthcare | $169.99 | +14.9% | +27.8% | −2.6% | $210.85B |
| 132 | IMVTImmunovantHealthcare | $37.18 | +29.5% | +27.1% | −17.3% | $7.69B |
| 133 | VORVor BiopharmaHealthcare | $20.17 | +5.8% | +26.8% | −19.6% | $1.24B |
| 134 | INNVInnovAge HoldingHealthcare | $9.34 | +3.5% | +26.4% | −22.9% | $1.27B |
| 135 | PCVXVaxcyteHealthcare | $68.45 | +2.5% | +26.2% | −7.3% | $10.84B |
| 136 | OMEROmerosHealthcare | $18.12 | −4.0% | +26.0% | −13.9% | $1.31B |
| 137 | LIVNLivaNovaHealthcare | $91.19 | +19.4% | +25.9% | −3.2% | $5.02B |
| 138 | BIIBBiogenHealthcare | $253.04 | +10.5% | +23.7% | −0.7% | $37.40B |
| 139 | IRONDisc MedicineHealthcare | $86.16 | +52.2% | +23.0% | −8.4% | $3.92B |
| 140 | RYTMRhythm PharmaceuticalsHealthcare | $114.62 | +32.3% | +22.3% | −2.6% | $7.95B |
| 141 | PACSPACS GroupHealthcare | $50.31 | +13.4% | +21.8% | 0.0% | $7.99B |
| 142 | ELANElanco Animal Health IncorporatedHealthcare | $26.54 | +18.4% | +21.7% | −1.1% | $13.27B |
| 143 | ALKSAlkermesHealthcare | $47.35 | +19.2% | +21.7% | −14.3% | $7.96B |
| 144 | RVMDRevolution MedicinesHealthcare | $182.44 | −3.2% | +21.7% | −17.5% | $39.46B |
| 145 | BLLNBillionToOneHealthcare | $109.99 | +16.5% | +21.4% | −26.7% | $5.25B |
| 146 | VTRSViatrisHealthcare | $21.05 | +22.0% | +21.2% | 0.0% | $24.13B |
| 147 | JNJJohnson & JohnsonHealthcare | $278.53 | +12.0% | +20.9% | −1.3% | $670.51B |
| 148 | STESTERISHealthcare | $254.43 | +16.8% | +20.5% | −5.3% | $24.71B |
| 149 | VRTXVertex PharmaceuticalsHealthcare | $545.20 | +12.4% | +20.3% | −2.4% | $138.23B |
| 150 | ZYMEZymeworksHealthcare | $29.52 | +17.8% | +20.1% | −6.2% | $2.05B |
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.